PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-22.17%
R&D reduction while CRVO shows 5.59% growth. Joel Greenblatt would examine competitive risk.
-22.47%
G&A reduction while CRVO shows 37.03% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
-12.79%
Other expenses reduction while CRVO shows 100.00% growth. Joel Greenblatt would examine efficiency.
-22.23%
Operating expenses reduction while CRVO shows 251.41% growth. Joel Greenblatt would examine advantage.
-22.23%
Total costs reduction while CRVO shows 15.98% growth. Joel Greenblatt would examine advantage.
10981.63%
Interest expense change of 10981.63% while CRVO maintains costs. Bruce Berkowitz would investigate control.
-12.79%
Both companies reducing D&A. Martin Whitman would check industry patterns.
22.24%
EBITDA growth while CRVO declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
22.23%
Operating income growth while CRVO declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
-88.23%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
18.34%
Pre-tax income growth while CRVO declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
88.23%
Tax expense change of 88.23% while CRVO maintains burden. Bruce Berkowitz would investigate strategy.
18.34%
Net income growth while CRVO declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
32.95%
EPS growth while CRVO declines. John Neff would investigate advantages.
32.95%
Diluted EPS growth while CRVO declines. John Neff would investigate advantages.
21.91%
Share count reduction below 50% of CRVO's 2.84%. Michael Burry would check for concerns.
21.91%
Diluted share reduction below 50% of CRVO's 2.84%. Michael Burry would check for concerns.